Search
A Memorial Sloan Kettering Cancer Center study shows that the use of MRI before or immediately after surgery in women with DCIS was not associated with reduced local recurrence or contralateral breast cancer rates.
A new type of CAR T cell therapy for multiple myeloma could shorten the time to treatment.
The Genetics Society of America medal honored Dr. Anderson, Chair of the Developmental Biology Program, for her lifetime contributions to the science of genetics.
Kenneth Manotti has been named Senior Vice President and Chief Development Officer at Memorial Sloan Kettering Cancer Center (MSK).
Learn about how cognitive behavioral therapy for insomnia (CBT-I) helps people with cancer improve sleep.
Learn about a new vaccine at MSK that could prevent neuroblastoma from returning after treatment.
Developed by scientists at MSK and the University of British Columbia/BC Cancer, the platform provides the deepest look yet into tumor evolution.
A preclinical study published in the journal Molecular Therapy by researchers at Memorial Sloan Kettering (MSK) provides evidence that radiation therapy could improve the efficacy of CAR T cell therapy for solid tumors.
The Gerstner Sloan Kettering Graduate School of Biomedical Sciences welcomed its ninth class of PhD students on July 21, 2014.
Scott N. Keeney, a member of the Molecular Biology Program within the Sloan Kettering Institute, was one of 56 researchers to be appointed a Howard Hughes Medical Institute (HHMI) investigator in 2008.